Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis

NCT00709722 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis

Interventions

DRUG: NKT-01

Sponsor

Nippon Kayaku Co., Ltd.